Authors:
SCHIRRMACHER K
MAYER A
WALDEN J
DUSING R
BINGMANN D
Citation: K. Schirrmacher et al., EFFECTS OF CARBAMAZEPINE ON MEMBRANE-PROPERTIES OF RAT SENSORY SPINALGANGLION-CELLS IN-VITRO, European neuropsychopharmacology, 5(4), 1995, pp. 501-507
Citation: P. Simon et al., NON-AMPHETAMINIC MECHANISM OF STIMULANT LOCOMOTOR EFFECT OF MODAFINILIN MICE, European neuropsychopharmacology, 5(4), 1995, pp. 509-514
Authors:
KOK FW
WESTENBERG HGM
THIJSSEN JHH
VANREE JM
Citation: Fw. Kok et al., ENDOCRINE AND CARDIOVASCULAR-RESPONSES TO A SERIES OF GRADED PHYSICALAND PSYCHOLOGICAL STRESS STIMULI IN HEALTHY-VOLUNTEERS, European neuropsychopharmacology, 5(4), 1995, pp. 515-522
Authors:
CANNIZZARO C
CANNIZZARO E
GAGLIANO M
MANGIAPANE N
Citation: C. Cannizzaro et al., BEHAVIORAL RESPONSIVENESS TO PICROTOXIN AND DESIPRAMINE IN ADULT-RATSPRENATALLY EXPOSED TO DIFFERENT BENZODIAZEPINE RECEPTOR AGONISTS, European neuropsychopharmacology, 5(4), 1995, pp. 523-526
Authors:
BUYUKOZTURK A
KANIT L
ERSOZ B
MENTES G
HARIRI NI
Citation: A. Buyukozturk et al., THE EFFECTS OF HYDERGINE ON THE MAO ACTIVITY OF THE AGED AND ADULT-RAT BRAIN, European neuropsychopharmacology, 5(4), 1995, pp. 527-529
Citation: ABSTRACTS OF THE 8TH CONGRESS OF THE EUROPEAN-COLLEGE-OF-NEUROPSYCHOPHARMACOLOGY - VENICE, ITALY, 30 SEPTEMBER 4 OCTOBER 1995, European neuropsychopharmacology, 5(3), 1995, pp. 159-420
Citation: A. Verma et Sk. Kulkarni, ROLE OF D-1 D-2 DOPAMINE AND N-METHYL-D-ASPARTATE (NMDA) RECEPTORS INMORPHINE-TOLERANCE AND DEPENDENCE IN MICE/, European neuropsychopharmacology, 5(2), 1995, pp. 81-87
Citation: Ay. Bespalov et Ee. Zvartau, SUBCHRONIC MORPHINE INCREASES AMPHETAMINE-INDUCED POTENTIATION OF BRAIN-STIMULATION REWARD - REVERSAL BY DNQX, European neuropsychopharmacology, 5(2), 1995, pp. 89-93
Authors:
SUZUKI M
KAWASAKI Y
MURATA M
SHIBATA R
KURACHI M
MORI H
Citation: M. Suzuki et al., EFFECTS OF 6-HYDROXYDOPAMINE LESIONS OF THE MEDIAL PREFRONTAL CORTEX ON LOCAL CEREBRAL BLOOD-FLOW AND D-1 AND D-2 DOPAMINE-RECEPTOR BINDINGIN RATS - A QUANTITATIVE AUTORADIOGRAPHIC STUDY, European neuropsychopharmacology, 5(2), 1995, pp. 95-101
Authors:
IWANAMI A
SHINBA T
SUMI M
OZAWA N
YAMAMOTO K
Citation: A. Iwanami et al., EFFECTS OF METAMFETAMINE ON AUDITORY P3 COMPONENT OF EVENT-RELATED POTENTIALS IN RATS, European neuropsychopharmacology, 5(2), 1995, pp. 103-106
Citation: Cg. Trolin et al., DECREASED METHIONINE ADENOSYLTRANSFERASE ACTIVITY IN ERYTHROCYTES OF PATIENTS WITH DEMENTIA DISORDERS, European neuropsychopharmacology, 5(2), 1995, pp. 107-114
Authors:
VEGAMATUSZCZYK J
AHLENIUS S
ENEROTH P
LARSSON K
Citation: J. Vegamatuszczyk et al., ADRENALECTOMY DOES NOT PREVENT THE ABILITY OF 8-OH-DPAT TO DECREASE THE EJACULATORY THRESHOLD IN MALE-RATS, European neuropsychopharmacology, 5(2), 1995, pp. 115-118
Authors:
VANDERSCHUREN LJMJ
STEIN EA
WIEGANT VM
VANREE JM
Citation: Ljmj. Vanderschuren et al., SOCIAL-ISOLATION AND SOCIAL-INTERACTION ALTER REGIONAL BRAIN OPIOID RECEPTOR-BINDING IN RATS, European neuropsychopharmacology, 5(2), 1995, pp. 119-127
Authors:
HUBAIN PP
SOUERY D
JONCK L
STANER L
VANVEEREN C
KERKHOFS M
MENDLEWICZ J
LINKOWSKI P
Citation: Pp. Hubain et al., RELATIONSHIP BETWEEN THE NEWCASTLE SCALE AND SLEEP POLYSOMNOGRAPHIC VARIABLES IN MAJOR DEPRESSION - A CONTROLLED-STUDY, European neuropsychopharmacology, 5(2), 1995, pp. 129-134
Citation: S. Tuinier et Wma. Verhoeven, DIMENSIONAL CLASSIFICATION AND BEHAVIORAL PHARMACOLOGY OF PERSONALITY-DISORDERS - A REVIEW AND HYPOTHESIS, European neuropsychopharmacology, 5(2), 1995, pp. 135-146
Citation: GUIDELINES ON PSYCHOTROPIC-DRUGS FOR THE EC - CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF GENERALIZED ANXIETY DISORDER, PANIC DISORDER AND OBSESSIVE-COMPULSIVE DISORDER, European neuropsychopharmacology, 5(2), 1995, pp. 151-155
Citation: C. Meylan et al., REVERSIBLE NEUTROPENIA DURING A COLD - POSSIBLE INVOLVEMENT OF RISPERIDONE - A CASE-REPORT, European neuropsychopharmacology, 5(1), 1995, pp. 1-2
Citation: W. Amery et G. Vandenbussche, REVERSIBLE NEUTROPENIA DURING A COLD - POSSIBLE INVOLVEMENT OF RISPERIDONE - A CASE-REPORT - COMMENT, European neuropsychopharmacology, 5(1), 1995, pp. 3-3
Citation: Sa. Montgomery et al., REDUCTION OF SUICIDAL THOUGHTS WITH PAROXETINE IN COMPARISON WITH REFERENCE ANTIDEPRESSANTS AND PLACEBO, European neuropsychopharmacology, 5(1), 1995, pp. 5-13
Authors:
PAPAKOSTAS YG
MARKIANOS M
PAPADIMITRIOU GN
ZERVAS IM
STEFANIS CN
Citation: Yg. Papakostas et al., EFFECTS OF METHYSERGIDE AND RITANSERIN ON THE PROLACTIN AND THYROTROPIN RESPONSES TO TRH IN DEPRESSED-PATIENTS, European neuropsychopharmacology, 5(1), 1995, pp. 15-18
Authors:
HALL H
HALLDIN C
NYBERG S
FARDE L
SEDVALL G
Citation: H. Hall et al., EFFECT OF CLOZAPINE AND RISPERIDONE ON 5-HT2 AND D-2-DOPAMINE RECEPTOR-BINDING IN THE POSTMORTEM HUMAN BRAIN - AN AUTORADIOGRAPHIC STUDY, European neuropsychopharmacology, 5(1), 1995, pp. 19-25
Citation: Hwj. Robbe et Jf. Ohanlon, ACUTE AND SUBCHRONIC EFFECTS OF PAROXETINE 20 AND 40 MG ON ACTUAL DRIVING, PSYCHOMOTOR PERFORMANCE AND SUBJECTIVE ASSESSMENTS IN HEALTHY-VOLUNTEERS, European neuropsychopharmacology, 5(1), 1995, pp. 35-42
Citation: M. Bijak et M. Papp, THE EFFECT OF CHRONIC TREATMENT WITH IMIPRAMINE ON THE RESPONSIVENESSOF HIPPOCAMPAL CA1 NEURONS TO PHENYLEPHRINE AND SEROTONIN IN A CHRONIC MILD STRESS MODEL OF DEPRESSION, European neuropsychopharmacology, 5(1), 1995, pp. 43-48